Paid Clinical Trials in Neptune City, NJ
As of September 2026, 57 paid clinical trials are recruiting in Neptune City, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Neptune City offers studies at sites including Jersey Shore University Medical Center for conditions such as Acute Myeloid Leukemia, Atrial Fibrillation, B Acute Lymphoblastic Leukemia, Immunoglobulin A Nephropathy. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Neptune City
Trials by drug in Neptune City
Filter results
51 clinical trials
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Pivotal Study for the Cardiac Performance System (CPS)
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Phagenyx® Registry Study
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
I-DECIDE After Bronchiolitis Hospitalization
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation
E-Mindfulness Approaches for Living After Breast Cancer
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Project: Every Child for Younger Patients With Cancer
Top Research Study Locations in Neptune City
Researchers run research studies in Neptune City, NJ at 22 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Jersey Shore University Medical Center | Atrial Fibrillation, ADHF, Alport Syndrome | 18 |
| Jersey Shore Medical Center | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Intracranial Meningioma | 17 |
| HMH Jersey Shore University Medical Center | Acute Treatment of Migraine, Dysphagia, Pediatric Migraine | 3 |
| HOPE Tower at Jersey Shore University Medical Center | Clostridoides Difficile Associated Disease, Pediatric Migraine | 2 |
| Hackensack Meridian Health Jersey Shore University Medical Center | Autism Spectrum Disorder (ASD), Clostridoides Difficile Associated Disease | 2 |
| 287 | Amyotrophic Lateral Sclerosis | 1 |
| HMH Jersey Shore University Medical Ctr. | Interstitial Lung Disease, Pulmonary Hypertension, Pulmonary Hypertension Due to Lung Diseases and Hypoxia | 1 |
| Hackensack Meridian | Nausea, Vomiting | 1 |
| Hackensack Meridian Health | Berger Disease, Bergers Disease, IgA Nephropathy | 1 |
| Hackensack Meridian Health - Jersey Shore University Medical Center | Acute Ischemic Stroke | 1 |
| Hackensack Meridian Health Jsumc | Small Cell Lung Cancer | 1 |
| Hope Tower | Acute Treatment of Migraine | 1 |
| Jersey Shore University Medical Center | Hackensack | Glioblastoma | 1 |
| John Theurer Cancer Center at JSUMC | Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer | 1 |
| John Theurer Cancer Center at Jersey Shore University Medical Center | Allogeneic Stem Cell Transplant Recipient | 1 |
| K. Hovnanian Children's Hospital, Jersey Shore University Medical Center | Bronchiolitis Acute | 1 |
| Local Institution - 0114 | Irritability Associated With Autism Spectrum Disorder | 1 |
| Local Institution - 0146 | Autism-Related Irritability, Schizophrenia | 1 |
| Meridian Health System | Non-Small Cell Lung Cancer | 1 |
| Neptune Surgical Institute | Lumbar Spinal Stenosis | 1 |
| Sleep Dynamics | OSA | 1 |
| TG Therapeutics Investigational Trial Site | Multiple Sclerosis, Relapsing Multiple Sclerosis | 1 |
Active & Upcoming Studies in Neptune City (2026)
Recruiting trials in Neptune City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (19 active studies)
- Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial · Phase 3 · National Cancer Institute (NCI)
- Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers · Phase 1, Phase 2 · Pfizer
Neurology & pain (6 active studies)
- Efficacy and Safety of Tenecteplase Among acutE Ischemic Stroke Patients With Recent Ingestion of Direct Oral Anticoagulant · Phase 3 · Hackensack Meridian Health
- Long-term Safety and Tolerability of BHV-7000 · Phase 2 · Biohaven Therapeutics Ltd.
Cardiovascular (6 active studies)
Mental health & behavior (2 active studies)
- A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Pediatric (2 active studies)
- InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS · Phase 3 · ONY
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Neptune City
- Acute Myeloid Leukemia (2 active studies)
- Atrial Fibrillation (2 active studies)
- B Acute Lymphoblastic Leukemia (2 active studies)
- Immunoglobulin A Nephropathy (2 active studies)
- Intracranial Meningioma (2 active studies)
- Mixed Phenotype Acute Leukemia (2 active studies)
Leading research sponsors in Neptune City
- Children's Oncology Group
- Hackensack Meridian Health
- National Cancer Institute (NCI)
- Pfizer
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Neptune City?
There are approximately 57 recruiting clinical trials in Neptune City, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Neptune City pay participants?
Most recruiting trials in Neptune City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Neptune City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Neptune City?
The most common conditions under active study in Neptune City include Acute Myeloid Leukemia (2), Atrial Fibrillation (2), B Acute Lymphoblastic Leukemia (2), Immunoglobulin A Nephropathy (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Neptune City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Neptune City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Neptune City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Neptune City?
Recruiting research sites in Neptune City include Jersey Shore University Medical Center, Jersey Shore Medical Center, HMH Jersey Shore University Medical Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Neptune City right now?
The largest active categories in Neptune City are Cancer & tumors (19), Neurology & pain (6), Cardiovascular (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.